Back to User profile » Dr Cynthia Besch-Williford
Paper published by Dr Cynthia Besch-Williford:
Original Research
![Noteworthy comment: This is an interesting small molecule that restores the function of mutant p53. It might be used with other current drugs for a bigger impact.](assets/img/article_icons/noteworthy.png)
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
A combination of p53-activating APR-246 and phosphatidylserine-targeting antibody potently inhibits tumor development in hormone-dependent mutant p53-expressing breast cancer xenografts
Liang Y, Mafuvadze B, Besch-Williford C, Hyder SM
Breast Cancer: Targets and Therapy 2018, 10:53-67
Published Date: 22 March 2018